AstraZeneca

NCT07391657

Phase 3Recruiting508 people6 Feb 2026clinicaltrials.gov

NCT07222917

Phase 2Active, not recruiting222 people30 Oct 2025clinicaltrials.gov

NCT07221253

Phase 3Recruiting1,100 people27 Oct 2025clinicaltrials.gov

NCT07218900

Phase 2Active, not recruiting76 people21 Oct 2025clinicaltrials.gov

NCT07216131

Phase 1Completed14 people14 Oct 2025clinicaltrials.gov

NCT07175415

CollaboratorPhase 1/2Not yet recruiting42 people16 Sept 2025clinicaltrials.gov

NCT07129993

CollaboratorPhase 2/3Recruiting630 people19 Aug 2025clinicaltrials.gov

NCT07088913

Phase 1Completed20 people28 Jul 2025clinicaltrials.gov

NCT07044336

Phase 3Recruiting800 people30 Jun 2025clinicaltrials.gov

NCT07022483

CollaboratorPhase 3Recruiting710 people15 Jun 2025clinicaltrials.gov

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2Recruiting152 people30 May 2025clinicaltrials.gov

NCT06979388

Phase 1Completed14 people19 May 2025clinicaltrials.gov

NCT06960577

Phase 3Recruiting150 people7 May 2025clinicaltrials.gov

NCT06948747

Phase 1Completed49 people29 Apr 2025clinicaltrials.gov

NCT06942910

Phase 2Active, not recruiting224 people24 Apr 2025clinicaltrials.gov

NCT06925854

Phase 1Completed12 people13 Apr 2025clinicaltrials.gov

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Phase 1Active, not recruiting41 people27 Mar 2025clinicaltrials.gov

NCT06858735

CollaboratorPhase 2Recruiting60 people5 Mar 2025clinicaltrials.gov

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

CollaboratorPhase 2Not yet recruiting29 people3 Mar 2025clinicaltrials.gov

NCT06764875

Phase 3Recruiting840 people9 Jan 2025clinicaltrials.gov

Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes

1 Nov 2026api.crossref.org

Most COPD is underdiagnosed and linked to higher mortality

The Lancet. Global health3 Oct 2026